Loading...
Tumor-Agnostic Drug Development
Therapies designed to target cancers that harbor specific molecular signatures have reshaped the landscape of oncologic drug development, and advances in next generation sequencing have led to an increase in the identification of these alterations across tumor types. Tumor-agnostic trial designs, su...
Na minha lista:
| Udgivet i: | Am Soc Clin Oncol Educ Book |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7506519/ https://ncbi.nlm.nih.gov/pubmed/30231313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EDBK_200831 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|